Post-operative Analgesic Effects of Dexamethasone Added to Bupivacaine in Transversusabdominis Plane (TAP) Block
NCT ID: NCT03863977
Last Updated: 2020-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
90 participants
INTERVENTIONAL
2019-03-15
2020-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dexmedetomidine to Levobupivacaine for Transversus Abdominis Plane Block in Elderly Patients Undergoing Inguinal Hernia Repair Surgery
NCT04971759
Dexmedetomidine Versus Fentanyl Added to Levobupivacaine for Transversus Abdominis Plane (TAP) Block
NCT03778671
Dexmedetomine vs Dexamethasone in TAB Block for Abdominal Surgries
NCT05323565
Analgesic Efficacy of Sequential Rapid Versus Slow Intrathecal Injection Of Dexmedetomidine Followed by of Hyperbaric Bupivacaine in Inguinal Hernia Repair Surgery
NCT06253260
Effect of Intravenous Dexamethasone on Duration of Hyperbaric Bupivacaine Spinal Anesthesia in Lower Abdominal Surgery
NCT04778189
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators designed this study to compare the postoperative analgesic effect of two doses of dexamethasone( 4 mg and 8 mg ) added to bupivacaine in ultrasound-guided TAP block for inguinal hernia repair.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dex4 group
After the surgery, the patients in this group will receive 4 mg dexamethasone added to 1mg/kg of 0.5% bupivacaine in the TAP block.
Dexamethasone
After the surgery, dexamethasone added to 1mg/kg of 0.5% bupivacaine in the TAP block.
Bupivacaine
After the surgery,1mg/kg of 0.5% bupivacaine in the TAP block.
Dex8 group
After the surgery, the patients in this group will receive 8 mg dexamethasone added to 1mg/kg of 0.5% bupivacaine in the TAP block.
Dexamethasone
After the surgery, dexamethasone added to 1mg/kg of 0.5% bupivacaine in the TAP block.
Bupivacaine
After the surgery,1mg/kg of 0.5% bupivacaine in the TAP block.
control group
After the surgery, the patients in this group will 1mg/kg of 0.5% bupivacaine in the TAP block.
Bupivacaine
After the surgery,1mg/kg of 0.5% bupivacaine in the TAP block.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexamethasone
After the surgery, dexamethasone added to 1mg/kg of 0.5% bupivacaine in the TAP block.
Bupivacaine
After the surgery,1mg/kg of 0.5% bupivacaine in the TAP block.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* physical status ASA I-II (by the American Society of Anesthesiologists),
* Elective unilateral open inguinal hernia repair,
* Under spinal anesthesia
Exclusion Criteria
* American society of anesthesiologist (ASA)class III-IV,
* known allergy to amino amide local anesthetics,
* skin infection and diseases at site of injection.
* coagulation disorders,
* patients with body mass index (BMI) \> 35 kg/m2,
* scrotal hernias,
18 Years
60 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amani Hassan Abdel-Wahab
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amany Hassan, Lectural
Role: PRINCIPAL_INVESTIGATOR
Assiut university, Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut university hospitals
Asyut, Assiut Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB:17100670
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.